Argo Blockchain
ARBK
BTCS Inc
BTCS
Canaan
CAN
Bit Origin
BTOG
Bitfarms
BITF
US Stock MarketDetailed Quotes
SRPT Sarepta Therapeutics
- 107.950
- -1.510-1.38%
Close Feb 14 16:00 ET
- 108.300
- +0.350+0.32%
Post 19:14 ET
10.31BMarket Cap70.10P/E (TTM)
111.205High107.610Low630.90KVolume109.840Open109.460Pre Close68.46MTurnover0.69%Turnover RatioLossP/E (Static)95.52MShares173.25052wk High8.44P/B9.84BFloat Cap102.15552wk Low--Dividend TTM91.13MShs Float181.830Historical High--Div YieldTTM3.28%Amplitude2.598Historical Low108.505Avg Price1Lot Size
Sarepta Therapeutics News
Sarepta Therapeutics | SCHEDULE 13D: Others
Sarepta Therapeutics | SCHEDULE 13G/A: Others
Sarepta Therapeutics | 8-K: Current report
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodino-Klapac Louise
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murray Dallan
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arif Bilal
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael
Sarepta Therapeutics | 8-K: Current report
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wigzell Hans Lennart Rudolf
Sarepta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Boor Kathryn Jean
Sarepta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rothfuss Cristin
Sarepta Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Rothfuss Cristin
Sarepta Therapeutics | 8-K: Current report
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodino-Klapac Louise
Sarepta Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(4.6%)
Sarepta Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Capital International Investors(6.7%)
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.